Company intelligence / Profile preview
Galen
- Ownership
- Private
- Employees
- ~82
- Development stage
- Other
Overview
Galen is a privately owned pharmaceutical company specializing in the sales and marketing of prescription medicines across pain management, dermatology, gastroenterology, and other specialty areas. The company has over 75 current products sold globally across 25 locations. It does not appear to have an internal drug discovery pipeline but expands its portfolio through acquisitions and partnerships for late-stage or close-to-market assets[3][7].
- Therapeutic areas
- GastroenterologyDermatologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Galen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Galen.